News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,117 Results
Type
Article (47025)
Company Profile (332)
Press Release (688760)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (212149)
Career Advice (2146)
Deals (36459)
Drug Delivery (108)
Drug Development (87085)
Employer Resources (177)
FDA (16950)
Job Trends (15446)
News (361135)
Policy (34099)
Tag
Academia (2796)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (52195)
ALS (101)
Alzheimer's disease (1480)
Antibody-drug conjugate (ADC) (144)
Approvals (16931)
Artificial intelligence (288)
Autoimmune disease (25)
Automation (16)
Bankruptcy (370)
Best Places to Work (12037)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (236)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (299)
Cancer (2406)
Cardiovascular disease (194)
Career advice (1798)
Career pathing (31)
CAR-T (164)
Cell therapy (462)
Cervical cancer (21)
Clinical research (70812)
Collaboration (897)
Company closure (1)
Compensation (569)
Complete response letters (24)
COVID-19 (2774)
CRISPR (46)
C-suite (266)
Cystic fibrosis (107)
Data (2326)
Decentralized trials (2)
Denatured (25)
Depression (52)
Diabetes (287)
Diagnostics (6730)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (125)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (88406)
Editorial (43)
Employer branding (22)
Employer resources (151)
Events (118105)
Executive appointments (767)
FDA (18314)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (802)
Gene editing (118)
Generative AI (26)
Gene therapy (336)
GLP-1 (778)
Government (4632)
Grass and pollen (6)
Guidances (108)
Healthcare (19794)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2927)
Inflammatory bowel disease (157)
Inflation Reduction Act (8)
Influenza (56)
Intellectual property (100)
Interviews (338)
IPO (16944)
IRA (40)
Job creations (3834)
Job search strategy (1534)
Kidney cancer (11)
Labor market (40)
Layoffs (516)
Leadership (22)
Legal (8130)
Liver cancer (78)
Lung cancer (341)
Lymphoma (158)
Machine learning (8)
Management (58)
Manufacturing (333)
MASH (74)
Medical device (13942)
Medtech (13947)
Mergers & acquisitions (20087)
Metabolic disorders (732)
Multiple sclerosis (86)
NASH (16)
Neurodegenerative disease (108)
Neuropsychiatric disorders (28)
Neuroscience (2067)
NextGen: Class of 2025 (6889)
Non-profit (4715)
Now hiring (40)
Obesity (390)
Opinion (240)
Ovarian cancer (78)
Pain (98)
Pancreatic cancer (89)
Parkinson's disease (158)
Partnered (22)
Patents (243)
Patient recruitment (118)
Peanut (51)
People (60030)
Pharmaceutical (75)
Pharmacy benefit managers (19)
Phase I (22203)
Phase II (31137)
Phase III (23159)
Pipeline (1313)
Policy (145)
Postmarket research (2794)
Preclinical (9298)
Press Release (68)
Prostate cancer (110)
Psychedelics (34)
Radiopharmaceuticals (265)
Rare diseases (413)
Real estate (6293)
Recruiting (67)
Regulatory (23576)
Reports (46)
Research institute (2542)
Resumes & cover letters (363)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (78)
Series A (138)
Series B (93)
Service/supplier (16)
Sickle cell disease (55)
Special edition (16)
Spinal muscular atrophy (158)
Sponsored (31)
Startups (3829)
State (2)
Stomach cancer (15)
Supply chain (72)
Tariffs (45)
The Weekly (39)
Vaccines (751)
Venture capitalists (42)
Weight loss (258)
Women's health (38)
Worklife (18)
Date
Today (301)
Last 7 days (889)
Last 30 days (3019)
Last 365 days (34037)
2025 (11762)
2024 (36637)
2023 (41579)
2022 (52955)
2021 (57491)
2020 (56048)
2019 (48813)
2018 (36876)
2017 (34005)
2016 (33609)
2015 (39544)
2014 (33364)
2013 (28396)
2012 (30503)
2011 (31126)
2010 (29202)
Location
Africa (805)
Alabama (54)
Alaska (7)
Arizona (247)
Arkansas (13)
Asia (41222)
Australia (6971)
California (6417)
Canada (2071)
China (556)
Colorado (277)
Connecticut (291)
Delaware (159)
Europe (91171)
Florida (952)
Georgia (220)
Idaho (61)
Illinois (570)
India (26)
Indiana (322)
Iowa (11)
Japan (168)
Kansas (107)
Kentucky (24)
Louisiana (13)
Maine (62)
Maryland (941)
Massachusetts (4855)
Michigan (223)
Minnesota (413)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (25)
Nevada (66)
New Hampshire (68)
New Jersey (1785)
New Mexico (31)
New York (1828)
North Carolina (1075)
North Dakota (9)
Northern California (2793)
Ohio (216)
Oklahoma (15)
Oregon (38)
Pennsylvania (1431)
Puerto Rico (13)
Rhode Island (34)
South America (1183)
South Carolina (26)
South Dakota (1)
Southern California (2412)
Tennessee (106)
Texas (959)
United States (24359)
Utah (195)
Virginia (158)
Washington D.C. (66)
Washington State (578)
West Virginia (3)
Wisconsin (58)
736,117 Results for "enzo biochem clinical labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
April 22, 2025
·
4 min read
Press Releases
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
March 18, 2025
·
7 min read
Press Releases
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
March 31, 2025
·
3 min read
Business
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem, Inc. announced financial results for the fiscal third quarter ended April 30, 2024.
June 13, 2024
·
9 min read
Press Releases
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
January 15, 2025
·
3 min read
Business
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.
March 13, 2024
·
8 min read
Press Releases
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
December 16, 2024
·
6 min read
Deals
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset Purchase Agreement dated March 16, 2023, as amended July 3, 2023.
July 24, 2023
·
3 min read
Business
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023.
December 15, 2023
·
4 min read
Business
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
Enzo Biochem, Inc., a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments.
February 1, 2024
·
3 min read
1 of 73,612
Next
